创新医疗
(002173)
| 流通市值：35.28亿 | | | 总市值：37.36亿 |
| 流通股本：4.24亿 | | | 总股本：4.49亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 201,344,535.99 | 805,585,526.56 | 607,166,382.27 | 405,325,757.73 |
| 营业收入 | 201,344,535.99 | 805,585,526.56 | 607,166,382.27 | 405,325,757.73 |
| 二、营业总成本 | 202,244,492.52 | 828,477,736.82 | 613,499,074.52 | 400,866,372.79 |
| 营业成本 | 176,622,830.79 | 713,376,688.89 | 528,492,021.22 | 346,934,717.51 |
| 税金及附加 | 3,238,757.4 | 9,775,931.67 | 4,786,298.77 | 3,190,422.9 |
| 销售费用 | 1,962,464.82 | 10,296,941.07 | 7,820,566.18 | 5,179,163.91 |
| 管理费用 | 22,771,232.23 | 107,726,934.05 | 82,935,407.04 | 52,894,434.94 |
| 财务费用 | -2,350,792.72 | -12,698,758.86 | -10,535,218.69 | -7,332,366.47 |
| 其中:利息费用 | 659,072.06 | 3,647,536.92 | 2,192,570.07 | 1,501,636.66 |
| 其中:利息收入 | 3,538,058.68 | 17,416,938.71 | 13,540,209.46 | 9,363,339.46 |
| 加:公允价值变动收益 | 199,882.7 | 78,554.1 | - | - |
| 加:投资收益 | -327,699.86 | -1,916,659.76 | -1,503,197.34 | -909,519.02 |
| 资产处置收益 | - | 1,059,985.19 | 1,059,985.19 | 998,076.04 |
| 资产减值损失(新) | - | -624,506.01 | 63,802.87 | 63,154.45 |
| 信用减值损失(新) | -1,376,230.41 | -2,711,985.09 | -4,221,820.26 | -3,420,860.92 |
| 其他收益 | 291,678.89 | 1,367,164.68 | 1,014,891.92 | 531,845.88 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -2,112,325.21 | -25,639,657.15 | -9,919,029.87 | 1,722,081.37 |
| 加:营业外收入 | 77,986.69 | 5,312,455.62 | 6,474,834.02 | 2,449,832.73 |
| 减:营业外支出 | 1,304,664.97 | 14,637,639.43 | 7,897,666.46 | 5,856,534.37 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -3,339,003.49 | -34,964,840.96 | -11,341,862.31 | -1,684,620.27 |
| 减:所得税费用 | -359,443.5 | -676,547.26 | 2,914,935.81 | 1,820,126.57 |
| 六、净利润 | -2,979,559.99 | -34,288,293.7 | -14,256,798.12 | -3,504,746.84 |
| 持续经营净利润 | -2,979,559.99 | -34,288,293.7 | -14,256,798.12 | -3,504,746.84 |
| 归属于母公司股东的净利润 | -2,977,863.39 | -34,287,743.35 | -14,214,765.78 | -3,453,782.41 |
| 少数股东损益 | -1,696.6 | -550.35 | -42,032.34 | -50,964.43 |
| (一)基本每股收益 | -0.01 | -0.08 | -0.03 | -0.01 |
| (二)稀释每股收益 | -0.01 | -0.08 | -0.03 | -0.01 |
| 九、综合收益总额 | -2,979,559.99 | -34,288,293.7 | -14,256,798.12 | -3,504,746.84 |
| 归属于母公司股东的综合收益总额 | -2,977,863.39 | -34,287,743.35 | -14,214,765.78 | -3,453,782.41 |
| 归属于少数股东的综合收益总额 | -1,696.6 | -550.35 | -42,032.34 | -50,964.43 |
| 公告日期 | 2024-04-27 | 2024-04-13 | 2023-10-28 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |